Next Article in Journal
Assessment of Chemical and Physico-Chemical Properties of Cyanobacterial Lipids for Biodiesel Production
Previous Article in Journal
pH-Dependent Solution Structure and Activity of a Reduced Form of the Host-Defense Peptide Myticin C (Myt C) from the Mussel Mytilus galloprovincialis
Article Menu

Export Article

Open AccessArticle
Mar. Drugs 2013, 11(7), 2347-2364; doi:10.3390/md11072347

Induction of Apoptosis by Fucoidan in Human Leukemia U937 Cells through Activation of p38 MAPK and Modulation of Bcl-2 Family

Department of Pharmacy, Pusan National University, Busan 609-735, Korea
Department of Food and Nutrition, Dongeui University, Busan 614-714, Korea
Anti-Aging Research Center & Blue-Bio Industry Regional Innovation Center, Dongeui University, Busan 614-714, Korea
Department of Marine Life Sciences, Jeju National University, Jeju 690-756, Korea
Departments of Parasitology and Genetics, Kosin University College of Medicine, Busan 602-702, Korea
Department of Urology, Chungbuk National University College of Medicine, Cheongju 361-763, Korea
Department of Anatomy and Cell Biology, College of Medicine, Dong-A University, Busan 602-714, Korea
Department of Biochemistry, Dongeui University College of Oriental Medicine, Busan 614-052, Korea
Authors to whom correspondence should be addressed.
Received: 26 April 2013 / Revised: 30 May 2013 / Accepted: 13 June 2013 / Published: 4 July 2013
View Full-Text   |   Download PDF [1159 KB, uploaded 24 February 2015]   |  


The present study investigated possible mechanisms on the apoptosis induction of human leukemic cells by fucoidan, a sulfated polysaccharide found in marine algae. Fucoidan treatment of cells resulted in inhibition of growth and induction of apoptosis, as measured by 3-(4,5-dimetylthiazol-2-yl)-2,5-diphenyl-tetrazolium (MTT) assay, fluorescence microscopy, DNA fragmentation, and flow cytometry analysis. The increase in apoptosis was associated with the proteolytic activation of caspases, Bid cleavage, insertion of pro-apoptotic Bax into the mitochondria, release of cytochrome c from mitochondria to cytosol, and loss of mitochondria membrane potential (MMP) in U937 cells. However, apoptosis induced by fucoidan was attenuated by caspase inhibitors, indicating that fucoidan-induced apoptosis was dependent on the activation of caspases. Furthermore, fucoidan treatment effectively activated the p38 mitogen-activated protein kinase (MAPK) and p38 MAPK inhibitor, SB203580, and significantly reduced fucoidan-induced apoptosis through inhibition of Bax translocation and caspases activation, suggesting that the activation of p38 MAPK may play a key role in fucoidan-induced apoptosis. In addition, the authors found fucoidan-induced significantly attenuated in Bcl-2 overexpressing U937 cells, and pretreatment with fucoidan and HA 14-1, a small-molecule Bcl-2 inhibitor, markedly increased fucoidan-mediated apoptosis in Bcl-2 overexpressing U937 cells. Our findings imply that we may attribute some of the biological functions of p38 MAPK and Bcl-2 to their ability to inhibit fucoidan-induced apoptosis. View Full-Text
Keywords: fucoidan; leukemic cells; apoptosis; p38 MAPK; Bcl-2 fucoidan; leukemic cells; apoptosis; p38 MAPK; Bcl-2

Figure 1

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Park, H.S.; Hwang, H.J.; Kim, G.-Y.; Cha, H.-J.; Kim, W.-J.; Kim, N.D.; Yoo, Y.H.; Choi, Y.H. Induction of Apoptosis by Fucoidan in Human Leukemia U937 Cells through Activation of p38 MAPK and Modulation of Bcl-2 Family. Mar. Drugs 2013, 11, 2347-2364.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top